Montara Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 8

Montara Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to enhance the safety and efficacy of treatments for neurological diseases. The company specializes in brain-specific pharmacology by leveraging human genetics and machine learning to identify and validate drug targets, enabling medical professionals to develop therapies for previously undruggable targets and improving treatment outcomes for patients with neurological conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (310)

Montara Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Montara Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 09-Jun-2026 $1M Completed Pre-Clinical Trials
3. Grant 21-Mar-2025 Completed Pre-Clinical Trials
2. Seed Round 26-Feb-2025 $20M $28M Completed Pre-Clinical Trials
1. Seed Round 19-Jan-2024 $8M $8M Completed Pre-Clinical Trials
To view Montara Therapeutics’s complete valuation and funding history, request access »

Montara Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Montara Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Montara Therapeutics Patents

Montara Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026060039-A1 Central nervous system-selective activity of lrrk2 inhibitors Pending 10-Sep-2024
WO-2026060039-A8 Central nervous system-selective activity of lrrk2 inhibitors Pending 10-Sep-2024
WO-2026060044-A1 Central nervous system-selective activity of lxr agonists Pending 10-Sep-2024
WO-2026060044-A8 Central nervous system-selective activity of lxr agonists Pending 10-Sep-2024
WO-2026060044-A9 Central nervous system-selective activity of lxr agonists Pending 10-Sep-2024
To view Montara Therapeutics’s complete patent history, request access »

Montara Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Montara Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Michael J. Fox Foundation Limited Partner
Bayshore Global Management Family Office Minority
BEVC (Berkeley) Venture Capital Minority
Angel (individual) Minority
Dolby Family Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Montara Therapeutics FAQs

  • When was Montara Therapeutics founded?

    Montara Therapeutics was founded in 2023.

  • Where is Montara Therapeutics headquartered?

    Montara Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Montara Therapeutics?

    Montara Therapeutics has 24 total employees.

  • What industry is Montara Therapeutics in?

    Montara Therapeutics’s primary industry is Drug Discovery.

  • Is Montara Therapeutics a private or public company?

    Montara Therapeutics is a Private company.

  • What is Montara Therapeutics’s current revenue?

    The current revenue for Montara Therapeutics is .

  • How much funding has Montara Therapeutics raised over time?

    Montara Therapeutics has raised $28M.

  • Who are Montara Therapeutics’s investors?

    Michael J. Fox Foundation, Bayshore Global Management, BEVC (Berkeley), , and Dolby Family Ventures are 5 of 8 investors who have invested in Montara Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process